ARTICLE | Company News
Medivation, Astellas sales and marketing update
April 27, 2015 7:00 AM UTC
Germany’s Institute for Quality and Efficiency in Healthcare (IQWiG) said in an assessment that Xtandi enzalutamide from Astellas has “major” added benefit over “watchful waiting” in men ages 75 and ...